Contracting the release analytics of drug products requires a trusting partnership between client and contractor and therefore represents the closest form of collaboration. For some clients, with whom we have often established long-term collaboration, we perform the analysis for the market release of drug products, but also of active ingredients, raw materials, excipients and intermediates.
With this form of collaboration, we serve as an extended workbench and deliver the analytical results, that our customers rely on for batch release. In doing so, we successfully overcome the major challenge of guaranteeing, not only very high quality standards, but also a high degree of compliance to delivery dates in conjunction with short turnaround times. In order for this partnership to be successful, both parties must establish good communication structures to coordinate sample dispatch on the one hand and laboratory capacity planning on the other.
In the field of release analytics, we also offer fixed bookable capacity contingents if the scheduling of batches to be released is not possible, in order to guarantee a provision of required resources even at any time.
The external analysis of release relevant routine analytics expands the analytical expertise of our customers and increases their flexibility and productivity by keeping a constant headcount.